Joints

"Joints" is not the name of a specific molecule or therapeutic target. In the context of neurobiology and physiology, **joint receptors** are specialized sensory nerve endings located within joint capsules and ligaments. These include free nerve endings and encapsulated mechanoreceptors that detect mechanical changes such as pressure, stretch, and movement within the joint[1][3]. Their primary function is to contribute to proprioception by sensing limb position and movement; however, their precise physiological role remains incompletely understood[3][4]. Joint receptors are not considered druggable molecular targets like enzymes or receptors but rather anatomical structures composed of various cell types. Therefore, "Joints" as a target is incorrect for structured pharmacological data extraction. Key points supporting this assessment: - There is no canonical molecule named "Joints"; it refers to anatomical structures. - The relevant entities at the molecular level would be "joint mechanoreceptors" or specific types such as Ruffini endings or Pacinian corpuscles. - No drugs directly interact with "joints" as a molecular entity; therapies for joint diseases typically target inflammation pathways (e.g., TNF inhibitors) rather than these sensory structures. In summary, "Joints" does not correspond to a single defined therapeutic target suitable for structured pharmacological annotation[1][3][4].

Other names

Joint receptorsarticular mechanoreceptors